Advanced Solid Tumors: STX-478 Treatment Study

We are investigating the effects of STX-478 alone and with other cancer drugs for people with advanced solid tumors. This study aims to see how well these treatments work together.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Département d’Oncologie Médicale
Bordeaux, France
Centre Leon Berard
Meyzieu, France
Oncopole Claudius Regaud
Portet-sur-Garonne, France

Sponsor: Scorpion Therapeutics Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.